Overview
At Nanotreat Inc., we believe that collaboration is the key to driving innovation and advancing the frontiers of medical science. Our partnerships with leading research institutions, universities, healthcare organizations, and industry leaders enable us to accelerate the development of cutting-edge nanoparticle-based therapies. Together, we are working to create solutions that address some of the most pressing health challenges, including the prevention and treatment of viral infections like SARS-CoV-2.
Our Key Collaborations
University of Manitoba
Focus:In collaboration with the University of Manitoba’s Department of Pharmacology and Therapeutics, our research focuses on developing and testing lipid nanoparticle (LNP) formulations. This partnership has advanced our LNP-Trap and LNP-Trim technologies, offering key insights into their efficacy and safety in preventing viral infections.
Impact: Our partnership with the University of Manitoba has led to significant breakthroughs in the use of LNPs for localized antiviral therapies, contributing to the scientific community through numerous publications and shared research findings.
Precision NanoSystems
Focus: Precision NanoSystems provides us with advanced microfluidic mixing technology, which is essential for the precise formulation of our LNP-based therapies. Our collaboration with this industry leader allows us to consistently produce high-quality nanoparticles that are optimized for gene delivery and virus neutralization.
Impact: The partnership with Precision NanoSystems has significantly enhanced our production capabilities, allowing us to scale our operations and bring our therapies closer to commercialization.
ACROBiosystems
Focus: ACROBiosystems collaborates with us in the development of specialized reagents and proteins that are critical for our LNP-Trap formulations. Their expertise in recombinant protein production supports the customization of our nanoparticle surface ligands, enabling us to target specific viral pathogens with greater precision.
Impact: This collaboration has resulted in the development of highly effective LNP formulations that demonstrate superior binding to viral spike proteins, enhancing the potential for broad-spectrum antiviral therapies.
Global Clinical Research Networks
Focus: Our partnerships with global clinical research networks facilitate the execution of multi-center clinical trials across diverse geographic regions. These collaborations ensure that our clinical studies are conducted according to the highest ethical standards and that they reflect the varied populations that may benefit from our therapies.
Impact: By working with international clinical partners, we are able to gather comprehensive data on the safety and efficacy of our treatments, accelerating the path to regulatory approval and global distribution.
Children’s Hospital Research Institute of Manitoba (CHRIM)
Focus: CHRIM is a crucial partner in our mission to develop therapies that are safe and effective for vulnerable populations, especially children. Our collaborative research includes both preclinical and clinical studies focused on assessing the safety and suitability of our nasal spray formulations specifically in pediatric populations.
Impact: This partnership has enabled us to effectively address the unique needs of pediatric patients, ensuring that our treatments are carefully designed to be suitable for use across all age groups.
Why We Collaborate
Shared Vision
We partner with organizations that share our commitment to improving global health through innovation. These collaborations allow us to leverage a wide range of expertise, from cutting-edge research and development to large-scale clinical testing and beyond.
Accelerated Innovation:
Collaborations enable us to combine resources, knowledge, and technology to solve complex challenges more efficiently. By working together, we can bring new treatments to market faster and more effectively than we could alone.
Global Impact
Our partnerships help us extend the reach of our innovations, ensuring that they can benefit people worldwide. Whether through clinical trials, academic research, or industry collaborations, our goal is to make a meaningful impact on public health on a global scale.
MON – FRI 9AM-5PM CST
Sales | Support | Investor Relations
info@nanotreat.ca
Need help? send an e-mail
+1(431)222-3009
Any questions? Reach Us Anytime